A novel, non-opioid, selective orexin-1 receptor antagonist for the treatment of substance use disorders
{{output}}
There is a pressing need for novel treatments for substance use disorders to address increasing rates of addiction and drug overdose. Preclinical studies have shown that the orexin (hypocretin) system in the brain, mediated primarily by the orexin 1 receptor, ... ...
